Enes Erul, Oncology Fellow at Ankara University, shared on LinkedIn:
“I still remember hearing the term ‘personalized medicine’ during my first year at Ankara University Faculty of Medicine in 2011. It sounded almost utopian to me. Years later, it meant a great deal to stand on a stage in Madrid and tauk about how we can bring part of that promise to more patients.
About two years ago, my mentor, my professor Yüksel Ürün, introduced me to the International Society of Liquid Biopsy (ISLB). I found a community that felt like family. I’ve had the chance to learn from people who have shaped the field and to work alongside early-career colleagues whose energy and drive make me want to do more.
What stands out to me is how ISLB’s leaders see the Young Committee as the next generation in liquid biopsy. They show it by trusting us to lead projects and giving us a voice at the congress. I’ve never seen a scientific society make so much room for early-career colleagues.
That support gave me the opportunity to speak at ISLB 2026 in Madrid. In ‘Liquid Biopsy Without Borders,’ I talked about how we can make liquid biopsy available to more patients in settings where it has demonstrated clinical value.
Precision oncology must be for all cancer patients, not just for the privileged few.
First, we need to make sure patients can access the molecular testing and treatments that we already know work.
My heartfelt thanks to Yüksel Ürun, my teachers and mentors at Ankara University, and all the colleagues I’ve had the chance to work with.
I’m proud to be part of Ankara University, and I’ll continue to do my best to represent it through our research.”
Other articles about Enes Erul on OncoDaily.
